Showing results (1-10 of 135) with videos related to
Sort By:
Pageof 14
JRSM Cardiovascular Disease|January 6, 2021
Inter-reader agreement of 18F-FDG PET/CT for the quantification of carotid artery plaque inflammationKjersti Johnsrud, Therese Seierstad, David Russell, et al.Journal of Alzheimer'S Disease : JAD|May 23, 2022
Alzheimer's Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects-Atherosclerosis for a StartPoul F Høilund-Carlsen, Mona-Elisabeth Revheim, Abass AlaviActa Radiologica (Stockholm, Sweden : 1987)|May 17, 2017
Respiratory motion during 90Yttrium PET contributes to underestimation of tumor dose and overestimation of normal liver tissue doseLine Ausland, Mona-Elisabeth Revheim, Arne Skretting, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 14, 2017
The prognostic value of 18F-FDG PET/CT prior to liver transplantation for nonresectable colorectal liver metastasesHarald Grut, Svein Dueland, Pål Dag Line, et al.Nuclear Medicine Communications|April 24, 2018
Importance of 18F-FDG PET/CT to select patients with nonresectable colorectal liver metastases for liver transplantationHarald Grut, Mona-Elisabeth Revheim, Pål-Dag Line, et al.European Physical Journal Plus|April 3, 2023
The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19Matthew T Griffin, Thomas J Werner, Abass Alavi, et al.BMJ Case Reports|November 14, 2014
Adrenocortical carcinoma mimicking lung cancer and responding to vinorelbine/carboplatin and pemetrexed/carboplatinOluf Dimitri Røe, Per Arne Oppegaard, Mona-Elisabeth Revheim, et al.Clinical Nuclear Medicine|April 22, 2022
Aducanumab-Related Amyloid-Related Imaging Abnormalities: Paean or Lament?Poul F Høilund-Carlsen, Thomas J Werner, Abass Alavi, et al.Clinical Nuclear Medicine|April 6, 2022
Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely NotAbass Alavi, Thomas J Werner, Poul Flemming Høilund-Carlsen, et al.Clinical Nuclear Medicine|June 14, 2023
FDG PET (and MRI) for Monitoring Immunotherapy in Alzheimer DiseasePoul F Høilund-Carlsen, Mona-Elisabeth Revheim, Abass Alavi, et al.Pageof 14